Axogen, Inc.

NasdaqCM:AXGN Stock Report

Market Cap: US$804.0m

Axogen Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.1yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Is Axogen (NASDAQ:AXGN) Using Too Much Debt?

Jan 14
Is Axogen (NASDAQ:AXGN) Using Too Much Debt?

Axogen: Well Placed To Capitalize Growth At Higher Multiples

Jan 07

Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 29% Price Jump

Dec 24
Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 29% Price Jump

Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely

Sep 14
Even With A 28% Surge, Cautious Investors Are Not Rewarding AxoGen, Inc.'s (NASDAQ:AXGN) Performance Completely

Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?

Aug 20
Would AxoGen (NASDAQ:AXGN) Be Better Off With Less Debt?

A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb

Jul 29
A Piece Of The Puzzle Missing From AxoGen, Inc.'s (NASDAQ:AXGN) 28% Share Price Climb

Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost

Jun 12
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 27% Share Price Boost

Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?

Apr 16
Is AxoGen (NASDAQ:AXGN) Using Too Much Debt?

Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump

Mar 28
Positive Sentiment Still Eludes AxoGen, Inc. (NASDAQ:AXGN) Following 26% Share Price Slump

Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost

Jan 26
Market Might Still Lack Some Conviction On AxoGen, Inc. (NASDAQ:AXGN) Even After 33% Share Price Boost

We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt

Sep 10
We Think AxoGen (NASDAQ:AXGN) Has A Fair Chunk Of Debt

Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues

Aug 09
Market Cool On AxoGen, Inc.'s (NASDAQ:AXGN) Revenues

AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?

Jan 13
AxoGen (NASDAQ:AXGN) Has Debt But No Earnings; Should You Worry?

CEO

Axogen has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Nir Naor
Chief Financial Officer1.1yrsUS$509.68k0.59%
$ 4.8m
Karen Zaderej
Advisorless than a yearUS$5.53m2.6%
$ 20.9m
Erick DeVinney
Chief Innovation Officer1yrUS$1.51m0.30%
$ 2.4m
Craig Swandal
Vice President of Operationsno datano datano data
Harold Tamayo
Vice President of Finance & Investor Relationsno datano datano data
Marc Began
Executive VP1.8yrsno datano data
Doris Quackenbush
Vice President of Sales3yrsno datano data
Jens Kemp
Chief Marketing Officer1.9yrsno datano data
Ivica Ducic
Chief Medical Officer1yrno datano data

1.1yrs

Average Tenure

56yo

Average Age

Experienced Management: AXGN's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Paul Thomas
Independent Chairman of the Board4.3yrsUS$220.00k0.049%
$ 390.9k
Guido Neels
Independent Director9.4yrsUS$217.50k0.18%
$ 1.5m
Bruce Mast
Member of Board of Advisorno datano datano data
David Muir
Member of Board of Advisorno datano datano data
John Johnson
Independent Director3.5yrsUS$215.00k0.042%
$ 335.5k
Kathy Weiler
Independent Director1.1yrsUS$293.37kno data
Alan Levine
Independent Director5.7yrsUS$217.50k0.069%
$ 551.1k
Amy Wendell
Independent Lead Director8.3yrsUS$255.00k0.18%
$ 1.5m
William Burke
Independent Director2.5yrsUS$220.00k0.063%
$ 509.8k
Joseph Tyndall
Independent Director2.1yrsUS$205.00k0.051%
$ 412.1k

3.9yrs

Average Tenure

60yo

Average Age

Experienced Board: AXGN's board of directors are considered experienced (3.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 23:04
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Axogen, Inc. is covered by 17 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael GormanBTIG
Caitlin CroninCanaccord Genuity
William PlovanicCanaccord Genuity